Why the study?
Hepatitis E virus causes acute and potentially chronic disease with high mortality in pregnant women, prompting efforts to produce recombinant virus-like particles containing 112-608aa of the ORF2 protein in Pichia pastoris.
Population
BALB/c mice
Comparison
Immunization with Pichia pastoris-produced 112-608aa ORF2 virus-like particles
Design
Preclinical laboratory and animal study
Authors
Loading...
Preclinical HEV VLP data support vaccine candidate pursuit; leaves open human immunogenicity and efficacy trials.
Recombinant HEV VLPs produced in P. pastoris induce a potent immune response in mice, suggesting potential as a diagnostic and prophylactic candidate.
Gupta et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: